BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16980942)

  • 1. Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.
    Körner M; Burckhardt E; Mazzucchelli L
    Mod Pathol; 2006 Dec; 19(12):1615-23. PubMed ID: 16980942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
    Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
    Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
    Körner M; Burckhardt E; Mazzucchelli L
    J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
    Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(9):924-7. PubMed ID: 23119109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
    Mhawech P; Kinkel K; Vlastos G; Pelte MF
    Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.
    Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD
    Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Transformation of Pelvic Endometriosis: Case Series and Review of the Literature.
    Jaiman S; Pochiraju M; Gundabattula SR; Surampudi K; Narayana Rao DV; Kandikattu S
    Int J Surg Pathol; 2015 Sep; 23(6):465-71. PubMed ID: 25911569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.
    Uzan C; Darai E; Valent A; Graesslin O; Cortez A; Rouzier R; Vielh P
    Virchows Arch; 2009 May; 454(5):525-9. PubMed ID: 19294416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
    Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
    Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: to a link between endometriosis and endometrioid ovarian cancer.
    Keita M; AinMelk Y; Pelmus M; Bessette P; Aris A
    J Obstet Gynaecol Res; 2011 Feb; 37(2):99-107. PubMed ID: 21083841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p53 mutation in the carcinomas arising from endometriosis.
    Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
    Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic aspects on endometrial hyperplasia and neoplasia.
    Sivridis E; Giatromanolaki A
    Virchows Arch; 2001 Aug; 439(2):118-26. PubMed ID: 11561751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometriosis-related ovarian tumors].
    Schmidt D; Ulrich U
    Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis.
    Prefumo F; Venturini PL; Fulcheri E
    Int J Gynecol Pathol; 2003 Jan; 22(1):83-8. PubMed ID: 12496703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.